CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Thursday reported a loss of $44.8 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 46 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.
The biotechnology company posted revenue of $4.1 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $9.6 million.
Momenta shares have risen 25% since the beginning of the year. The stock has decreased 33% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at https://www.zacks.com/ap/MNTA